NeuroOne Medical Technologies Corporation (NMTC)

Every figure this model derived for NMTC, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 109,536 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 3,043,028 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 5,788,801 AssetsCurrent 2026-06-30
current liabilities 2,041,427 LiabilitiesCurrent 2026-06-30
equity 3,767,543 StockholdersEquity 2026-06-30
ocf -7,052,007 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 9,468,715 Revenues 2026-06-30
sbc 1,412,727 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up NMTC on one particular measure came for.

RatioValue
cash operating margin-66.01
current ratio2.84
current ratio reported2.84
deferred revenue growth16777.62
fcf margin-75.63
growth cv1.75
operating margin-83.43
owner earnings margin-90.55
revenue growth42.84
revenue growth per share42.84
roic-861.39
rule of 40-40.59
sbc pct revenue14.92

What to be careful about

What this model itself distrusts about NMTC's figures. Written by the derivation as it ran, not added afterwards.